What is HSTC's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.10B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HSTC?

P/E (TTM) is n/a and 52-week range is $0.01 to $1.05 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HSTC figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HSTC?

The company profile lists revenue (TTM) near $15M, net income (TTM) near $-213M, EPS (TTM) near $-0.01 when available from the market-data feed. Figures are informational and may lag live markets.

Where is HST Global Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Virginia Beach, Virginia, US, 141.4M shares outstanding, ISIN US40432E2028 when available from company profile and filing metadata.

HST Global Inc

$HSTC

Health Care · Biotechnology

IR Run Scenarios

$0.70

+0.00%

HST Global Inc

$HSTC

Health Care · Biotechnology

IR Run Scenarios

$0.70

+0.00%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

HST Global, Inc. is a health and wellness biotechnology company, which engages in the acquisition of a network of wellness centers that are focused on the homeopathic and alternative treatments of late-stage cancer. The company is headquartered in Virginia Beach, Virginia. The firm is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The firm intends to acquire innovative products for the treatment of life-threatening diseases. The firm primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The company is also focused on funding and developing cutting-edge software solutions. The firm has not generated any revenue.

Website

www.hstglobal.com/

IPO

1986-09-24

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US40432E2028

Headquarters

Virginia Beach, Virginia, US

Shares outstanding

141.4M

NAICS sector

Professional, Scientific, and Technical Services

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

HST Global, Inc. is a health and wellness biotechnology company, which engages in the acquisition of a network of wellness centers that are focused on the homeopathic and alternative treatments of late-stage cancer. The company is headquartered in Virginia Beach, Virginia. The firm is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The firm intends to acquire innovative products for the treatment of life-threatening diseases. The firm primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The company is also focused on funding and developing cutting-edge software solutions. The firm has not generated any revenue.

Website

www.hstglobal.com/

IPO

1986-09-24

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)